Literature DB >> 3864398

Imipramine for the treatment of fibrositis: a therapeutic trial.

A J Wysenbeek, F Mor, Y Lurie, A Weinberger.   

Abstract

Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period: 14 of them due to lack of response, while two of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects, while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864398      PMCID: PMC1001766          DOI: 10.1136/ard.44.11.752

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation.

Authors:  H Moldofsky; P Scarisbrick
Journal:  Psychosom Med       Date:  1976 Jan-Feb       Impact factor: 4.312

3.  Diagnosis and management of fibrositis syndrome and psychogenic rheumatism.

Authors:  W P Beetham
Journal:  Med Clin North Am       Date:  1979-03       Impact factor: 5.456

4.  Fibrositis and psychologic disturbance.

Authors:  T C Payne; F Leavitt; D C Garron; R S Katz; H E Golden; P B Glickman; C Vanderplate
Journal:  Arthritis Rheum       Date:  1982-02

5.  Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points.

Authors:  S M Campbell; S Clark; E A Tindall; M E Forehand; R M Bennett
Journal:  Arthritis Rheum       Date:  1983-07

6.  Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls.

Authors:  M Yunus; A T Masi; J J Calabro; K A Miller; S L Feigenbaum
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

  6 in total
  7 in total

1.  Fibromyalgia: Does it Exist?

Authors:  O G Zadorozny
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

2.  Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia.

Authors:  K J Skeith; M S Hussain; R T Coutts; C Ramos-Remus; J A Avina-Zubieta; A S Russell
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

3.  A controlled study of two psychotropic agents for the relief of pain in osteoarthrosis.

Authors:  H A Bird; V Wright; P Le Gallez; R Bojar; J S Dixon
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12

4.  The skinache syndrome.

Authors:  C F Bassøe
Journal:  J R Soc Med       Date:  1995-10       Impact factor: 5.344

5.  Fibromyalgia--the effect of relaxation and hydrogalvanic bath therapy on the subjective pain experience.

Authors:  V Günther; E Mur; U Kinigadner; C Miller
Journal:  Clin Rheumatol       Date:  1994-12       Impact factor: 2.980

Review 6.  Fibrositis (fibromyalgia). A common non-entity?

Authors:  F D Hart
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

7.  [Treatment of chronic pain syndromes with antidepressants.].

Authors:  R Wörz; J Berlin
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.